{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-005307","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.073831+00:00","generated_at":"2026-06-26T09:51:12.899895+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Rallybio appoints Christine Nash and Hui Liu to board; Shannon to resign at annual meeting","bullets":["Board size increased from 8 to 10; Christine Nash and Hui Liu appointed as directors effective April 4, 2022.","Nash appointed to Compensation Committee; Liu appointed to Audit Committee.","Director Timothy Shannon to resign at Rallybio's 2022 annual meeting of shareholders.","Nash brings rare disease commercial/product launch experience; Liu brings business development and finance expertise."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-005307","json":"https://secwatch.observer/filing/0000950170-22-005307.json","markdown":"https://secwatch.observer/filing/0000950170-22-005307.md","text":"https://secwatch.observer/filing/0000950170-22-005307.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/rlyb-20220401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:51:12.899895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"62bb6bf32d","claim":"Hui Liu was appointed as Director at Rallybio Corp.","evidence_excerpt":"appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"656d92fe1d","claim":"Christine A. Nash was appointed as Director at Rallybio Corp.","evidence_excerpt":"appointed Christine A. Nash and Hui Liu, Ph.D., each to serve as a director to fill the newly created vacancies, effective April 4, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ae7e0d156a","claim":"Timothy Shannon resigned as Director at Rallybio Corp.","evidence_excerpt":"Timothy Shannon notified Rallybio that he would resign from the Board, effective at Rallybio’s 2022 annual meeting of shareholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022005307/0000950170-22-005307-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}